Mary Horowitz ری ٹویٹ کیا

ICYMI: The dual CD19- and CD20-directed, freshly administered CAR T-cell therapy zamtocabtagene autoleucel elicited a high response rate with deepening responses over time in R/R DLBCL. @niravshahmd @MedicalCollege @ASTCT @CIBMTR #Tandem23 ow.ly/yMI950MVuat
English








